PB2142: CLINICAL CHARACTERISTICS AND OUTCOMES OF NEWLY DIAGNOSED PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED LYMPHOMA ADMINISTERED HIGHLY ACTIVE ANTIRETROVIRAL THERAPY

Detalles Bibliográficos
Autores principales: Wang, C., Liu, J., Lei, H., Li, Y., Wu, J., Guo, B., Hu, R., Liu, T., Ding, Y., Hu, C., Liang, S., Xiao, C., Liang, X., Huang, D., Yang, T., Zhang, W., Yang, Z., Li, J., Nan, Y., Li, Q., Xiang, Y., Wu, Y., Liu, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431588/
http://dx.doi.org/10.1097/01.HS9.0000851400.39996.c1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431588/
http://dx.doi.org/10.1097/01.HS9.0000851400.39996.c1

Ejemplares similares